Term ends Sep 15, 2041 · High confidence
Held by Biofrontera, Inc.
Filed Jan 31, 2024 as application 29/926,745 · Granted Sep 15, 2026
Base term, 15 years from grant
Today
2026
2041
Clock starts
Sep 15, 2026
Sep 15, 2026
Term ends
Sep 15, 2041
Sep 15, 2041
base term
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
15 years from grant
Base term
No maintenance fees are payable on this kind of patent.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its base term, 15 years from grant, with no adjustment for prosecution delay. No maintenance fees are payable on this kind of patent. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 15 years from grant | Granted Sep 15, 2026 | Sep 15, 2041 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Computed term end | The steps above, in order | Sep 15, 2041 | High confidence |
This family
| US 12,472,374 | In force Oct 2040 | Oct 2040 |
| US 11,235,169 | In force Oct 2040 | Oct 2040 |
| US D1,021,120 | In force Apr 2039 | Apr 2039 |
| Application 18/248,672 | Pending not computed | not computed |
| US D1,148,164 | this patent Sep 2041 | Sep 2041 |
5 of 6 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 6, 2024 Reel 67648, frame 649 | Osterloh, Markus; Novak, Ben; Lubbert, Hermann | Biofrontera Pharma GmbH | Assignment of Assignor's Interest |
| Nov 5, 2025 Reel 73487, frame 1 | Biofrontera Pharma GmbH | Biofrontera, Inc. | Assignment of Assignor's Interest |
| Jan 26, 2026 Reel 74863, frame 943 | Biofrontera Pharma GmbH | Biofrontera, Inc. | Corrective Assignment to Correct the Execution Date Previously Recorded on Reel 73487 Frame 1. Assignor(S) Hereby Confirms the Assignment . |
| Jul 17, 2026 Reel 75311, frame 722 | Sinn, Christian | Biofrontera Pharma GmbH | Assignment of Assignor's Interest |
| Oct 20, 2026 Reel 76724, frame 292 | Biofrontera Pharma GmbH | Biofrontera, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center
No maintenance fees are payable on this kind of patent, so the record carries no fee events.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Sep 2041
Term ends Sep 15, 2041. No maintenance fees are payable on this kind of patent
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.